170 related articles for article (PubMed ID: 24170414)
1. Design, synthesis, and anticancer properties of novel benzophenone-conjugated coumarin analogs.
Lakshmi Ranganatha V; Zameer F; Meghashri S; Rekha ND; Girish V; Gurupadaswamy HD; Khanum SA
Arch Pharm (Weinheim); 2013 Dec; 346(12):901-11. PubMed ID: 24170414
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, angiopreventive activity, and in vivo tumor inhibition of novel benzophenone-benzimidazole analogs.
Ranganatha VL; Vijay Avin BR; Thirusangu P; Prashanth T; Prabhakar BT; Khanum SA
Life Sci; 2013 Nov; 93(23):904-11. PubMed ID: 24135459
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and tumor inhibitory activity of novel coumarin analogs targeting angiogenesis and apoptosis.
Vijay Avin BR; Thirusangu P; Lakshmi Ranganatha V; Firdouse A; Prabhakar BT; Khanum SA
Eur J Med Chem; 2014 Mar; 75():211-21. PubMed ID: 24534537
[TBL] [Abstract][Full Text] [Related]
4. Design and Synthesis of Coumarin Derivatives as Novel PI3K Inhibitors.
Ma CC; Liu ZP
Anticancer Agents Med Chem; 2017; 17(3):395-403. PubMed ID: 26902599
[TBL] [Abstract][Full Text] [Related]
5. Anti-tumor and proapoptotic effect of novel synthetic benzophenone analogues in Ehrlich ascites tumor cells.
Prabhakar BT; Khanum SA; Jayashree K; Salimath BP; Shashikanth S
Bioorg Med Chem; 2006 Jan; 14(2):435-46. PubMed ID: 16214348
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of coumarin heterocyclic derivatives with antioxidant activity and in vitro cytotoxic activity against tumour cells.
Manojkumar P; Ravi TK; Subbuchettiar G
Acta Pharm; 2009 Jun; 59(2):159-70. PubMed ID: 19564141
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of 4-(1,2,3-triazol-1-yl)coumarin derivatives as potential antitumor agents.
Zhang W; Li Z; Zhou M; Wu F; Hou X; Luo H; Liu H; Han X; Yan G; Ding Z; Li R
Bioorg Med Chem Lett; 2014 Feb; 24(3):799-807. PubMed ID: 24418772
[TBL] [Abstract][Full Text] [Related]
8. Design and Synthesis of Novel Coumarin Conjugated Acetamides as Promising Anticancer Agents: An In Silico and In Vitro Approach.
Mamatha SV; Belagali SL; Bhat M; Kumbar VM
Anticancer Agents Med Chem; 2021; 21(11):1431-1440. PubMed ID: 32664844
[TBL] [Abstract][Full Text] [Related]
9. KRC-408, a novel c-Met inhibitor, suppresses cell proliferation and angiogenesis of gastric cancer.
Hong SW; Jung KH; Park BH; Zheng HM; Lee HS; Choi MJ; Yun JI; Kang NS; Lee J; Hong SS
Cancer Lett; 2013 May; 332(1):74-82. PubMed ID: 23348694
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new conjugated coumarin-benzimidazole hybrids and their anticancer activity.
Paul K; Bindal S; Luxami V
Bioorg Med Chem Lett; 2013 Jun; 23(12):3667-72. PubMed ID: 23642480
[TBL] [Abstract][Full Text] [Related]
11. Benzophenone-nucleoside derivatives as telomerase inhibitors: Design, synthesis and anticancer evaluation in vitro and in vivo.
Shi JB; Chen LZ; Wang Y; Xiou C; Tang WJ; Zhou HP; Liu XH; Yao QZ
Eur J Med Chem; 2016 Nov; 124():729-739. PubMed ID: 27639364
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents.
Abdizadeh T; Kalani MR; Abnous K; Tayarani-Najaran Z; Khashyarmanesh BZ; Abdizadeh R; Ghodsi R; Hadizadeh F
Eur J Med Chem; 2017 May; 132():42-62. PubMed ID: 28340413
[TBL] [Abstract][Full Text] [Related]
13. Coumarin polysulfides inhibit cell growth and induce apoptosis in HCT116 colon cancer cells.
Saidu NE; Valente S; Bana E; Kirsch G; Bagrel D; Montenarh M
Bioorg Med Chem; 2012 Feb; 20(4):1584-93. PubMed ID: 22264758
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel coumarin-pyrazoline hybrids endowed with phenylsulfonyl moiety as antitumor agents.
Amin KM; Eissa AA; Abou-Seri SM; Awadallah FM; Hassan GS
Eur J Med Chem; 2013 Feb; 60():187-98. PubMed ID: 23291120
[TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, and Antiproliferative Evaluation of Novel Coumarin/2-Cyanoacryloyl Hybrids as Apoptosis Inducing Agents by Activation of Caspase-Dependent Pathway.
Zhang YY; Zhang QQ; Song JL; Zhang L; Jiang CS; Zhang H
Molecules; 2018 Aug; 23(8):. PubMed ID: 30087276
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new coumarin tethered isoxazolines as potential anticancer agents.
Lingaraju GS; Balaji KS; Jayarama S; Anil SM; Kiran KR; Sadashiva MP
Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3606-3612. PubMed ID: 30396758
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of new coumarin hybrids and insight into their mode of antiproliferative action.
Elshemy HAH; Zaki MA
Bioorg Med Chem; 2017 Feb; 25(3):1066-1075. PubMed ID: 28038941
[TBL] [Abstract][Full Text] [Related]
18. Quinazoline-based multi-tyrosine kinase inhibitors: synthesis, modeling, antitumor and antiangiogenic properties.
Conconi MT; Marzaro G; Urbani L; Zanusso I; Di Liddo R; Castagliuolo I; Brun P; Tonus F; Ferrarese A; Guiotto A; Chilin A
Eur J Med Chem; 2013 Sep; 67():373-83. PubMed ID: 23900004
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-angiogenesis activity of coumarin derivatives.
Lee S; Sivakumar K; Shin WS; Xie F; Wang Q
Bioorg Med Chem Lett; 2006 Sep; 16(17):4596-9. PubMed ID: 16793260
[TBL] [Abstract][Full Text] [Related]
20. Design, Synthesis and Biological Evaluation of 4, 6-Coumarin Derivatives as Anti- Cancer and Apoptosis-Inducing Agents.
Yan G; Luo J; Han X; Zhang W; Pu C; Zhou M; Zhong X; Hou X; Hou MZ; Li R
Anticancer Agents Med Chem; 2021; 21(17):2351-2367. PubMed ID: 33511941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
